116 related articles for article (PubMed ID: 8618882)
1. Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions.
Pfitzner E; Becker P; Rolke A; Schüle R
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12265-9. PubMed ID: 8618882
[TBL] [Abstract][Full Text] [Related]
2. Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha.
Sista ND; Barry C; Sampson K; Pagano J
Nucleic Acids Res; 1995 May; 23(10):1729-36. PubMed ID: 7784177
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
Sista ND; Pagano JS; Liao W; Kenney S
Proc Natl Acad Sci U S A; 1993 May; 90(9):3894-8. PubMed ID: 8387200
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
[TBL] [Abstract][Full Text] [Related]
5. Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1.
Darby TG; Meissner JD; Rühlmann A; Mueller WH; Scheibe RJ
Oncogene; 1997 Dec; 15(25):3067-82. PubMed ID: 9444955
[TBL] [Abstract][Full Text] [Related]
6. The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B.
Gutsch DE; Holley-Guthrie EA; Zhang Q; Stein B; Blanar MA; Baldwin AS; Kenney SC
Mol Cell Biol; 1994 Mar; 14(3):1939-48. PubMed ID: 8114725
[TBL] [Abstract][Full Text] [Related]
7. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.
Schepers A; Pich D; Hammerschmidt W
Virology; 1996 Jun; 220(2):367-76. PubMed ID: 8661388
[TBL] [Abstract][Full Text] [Related]
8. Expression of retinoid X receptors and COUP-TFI in a human salivary gland adenocarcinoma cell line.
Kyakumoto S; Nemoto T; Sato N; Ota M
Biochem Cell Biol; 1997; 75(6):749-58. PubMed ID: 9599664
[TBL] [Abstract][Full Text] [Related]
9. Physical interaction between retinoic acid receptor and the oncoprotein myb inhibits retinoic acid-dependent transactivation.
Pfitzner E; Kirfel J; Becker P; Rolke A; Schüle R
Proc Natl Acad Sci U S A; 1998 May; 95(10):5539-44. PubMed ID: 9576918
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif.
Chang YN; Dong DL; Hayward GS; Hayward SD
J Virol; 1990 Jul; 64(7):3358-69. PubMed ID: 2161945
[TBL] [Abstract][Full Text] [Related]
11. Repression by RAZ of Epstein-Barr virus bZIP transcription factor EB1 is dimerization independent.
Segouffin C; Gruffat H; Sergeant A
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1529-36. PubMed ID: 8757996
[TBL] [Abstract][Full Text] [Related]
12. Identification of the AP1-antagonism domain of retinoic acid receptors.
DiSepio D; Sutter M; Johnson AT; Chandraratna RA; Nagpal S
Mol Cell Biol Res Commun; 1999 Apr; 1(1):7-13. PubMed ID: 10329471
[TBL] [Abstract][Full Text] [Related]
13. Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation.
Baumann M; Mischak H; Dammeier S; Kolch W; Gires O; Pich D; Zeidler R; Delecluse HJ; Hammerschmidt W
J Virol; 1998 Oct; 72(10):8105-14. PubMed ID: 9733851
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal portion of domain E of retinoic acid receptors alpha and beta is essential for the recognition of retinoic acid and various analogs.
Ostrowski J; Hammer L; Roalsvig T; Pokornowski K; Reczek PR
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):1812-6. PubMed ID: 7892182
[TBL] [Abstract][Full Text] [Related]
15. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.
Sun CC; Thorley-Lawson DA
J Virol; 2007 Dec; 81(24):13566-77. PubMed ID: 17898050
[TBL] [Abstract][Full Text] [Related]
16. The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper.
Kouzarides T; Packham G; Cook A; Farrell PJ
Oncogene; 1991 Feb; 6(2):195-204. PubMed ID: 1847997
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the multimerization region of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) protein K-bZIP: the proposed leucine zipper region encodes a multimerization domain with an unusual structure.
Al Mehairi S; Cerasoli E; Sinclair AJ
J Virol; 2005 Jun; 79(12):7905-10. PubMed ID: 15919946
[TBL] [Abstract][Full Text] [Related]
18. Protein-protein interaction of retinoic acid receptor alpha and thyroid transcription factor-1 in respiratory epithelial cells.
Yan C; Naltner A; Conkright J; Ghaffari M
J Biol Chem; 2001 Jun; 276(24):21686-91. PubMed ID: 11274148
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7.
Rochette-Egly C; Adam S; Rossignol M; Egly JM; Chambon P
Cell; 1997 Jul; 90(1):97-107. PubMed ID: 9230306
[TBL] [Abstract][Full Text] [Related]
20. Atypical bZIP domain of viral transcription factor contributes to stability of dimer formation and transcriptional function.
Schelcher C; Al Mehairi S; Verrall E; Hope Q; Flower K; Bromley B; Woolfson DN; West MJ; Sinclair AJ
J Virol; 2007 Jul; 81(13):7149-55. PubMed ID: 17459922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
